Moreover, we analyzed triple correlation of USP22/PPARG/ACACA (or ACLY) and found that simultaneously high expression levels of USP22/PPARG/ACACA (or ACLY) had worse overall survival in HCC cohorts (Supplementary Fig. 8e). The gene discussed is ACLY; the disease is hepatocellular carcinoma.